302 related articles for article (PubMed ID: 33543326)
1. ImmunoPET imaging of multiple myeloma with [
Wang C; Chen Y; Hou YN; Liu Q; Zhang D; Zhao H; Zhang Y; An S; Li L; Hou J; Huang G; Liu J; Zhao YJ; Wei W
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2749-2760. PubMed ID: 33543326
[TBL] [Abstract][Full Text] [Related]
2. Annotating CD38 Expression in Multiple Myeloma with [
Wei W; Zhang D; Wang C; Zhang Y; An S; Chen Y; Huang G; Liu J
Mol Pharm; 2022 Oct; 19(10):3502-3510. PubMed ID: 34846151
[TBL] [Abstract][Full Text] [Related]
3. Annotating BCMA Expression in Multiple Myelomas.
Wei W; Zhang Y; Zhang D; Liu Q; An S; Chen Y; Huang G; Liu J
Mol Pharm; 2022 Oct; 19(10):3492-3501. PubMed ID: 34843261
[TBL] [Abstract][Full Text] [Related]
4. GPC3-targeted immunoPET imaging of hepatocellular carcinomas.
An S; Zhang D; Zhang Y; Wang C; Shi L; Wei W; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2682-2692. PubMed ID: 35147737
[TBL] [Abstract][Full Text] [Related]
5. ImmunoPET imaging of human CD8
Zhao H; Wang C; Yang Y; Sun Y; Wei W; Wang C; Wan L; Zhu C; Li L; Huang G; Liu J
J Nanobiotechnology; 2021 Feb; 19(1):42. PubMed ID: 33563286
[TBL] [Abstract][Full Text] [Related]
6. Preclinical development of novel PD-L1 tracers and first-in-human study of [
Zhang Y; Cao M; Wu Y; Malih S; Xu D; Yang E; Younis MH; Lin W; Zhao H; Wang C; Liu Q; Engle JW; Rasaee MJ; Guan Y; Huang G; Liu J; Cai W; Xie F; Wei W
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38580333
[TBL] [Abstract][Full Text] [Related]
7.
Kang L; Li C; Yang Q; Sutherlin L; Wang L; Chen Z; Becker KV; Huo N; Qiu Y; Engle JW; Wang R; He C; Jiang D; Xu X; Cai W
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1470-1481. PubMed ID: 34677626
[TBL] [Abstract][Full Text] [Related]
8. ImmunoPET imaging of CD38 expression in hepatocellular carcinoma using
Li S; England CG; Ehlerding EB; Kutyreff CJ; Engle JW; Jiang D; Cai W
Am J Transl Res; 2019; 11(9):6007-6015. PubMed ID: 31632568
[TBL] [Abstract][Full Text] [Related]
9. ImmunoPET imaging of Trop2 expression in solid tumors with nanobody tracers.
Huang W; Liang C; Zhang Y; Zhang D; An S; Wu Q; Li J; Zhao H; Wang C; Cui J; Bao Z; Huang G; Wei W; Liu J
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):380-394. PubMed ID: 37792026
[TBL] [Abstract][Full Text] [Related]
10. ImmunoPET imaging of CD38 in murine lymphoma models using
Kang L; Jiang D; England CG; Barnhart TE; Yu B; Rosenkrans ZT; Wang R; Engle JW; Xu X; Huang P; Cai W
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1372-1381. PubMed ID: 29450576
[TBL] [Abstract][Full Text] [Related]
11. Development of a New Folate-Derived Ga-68-Based PET Imaging Agent.
Brand C; Longo VA; Groaning M; Weber WA; Reiner T
Mol Imaging Biol; 2017 Oct; 19(5):754-761. PubMed ID: 28194631
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Development of CD38-Targeted [
Ghai A; Maji D; Cho N; Chanswangphuwana C; Rettig M; Shen D; DiPersio J; Akers W; Dehdashti F; Achilefu S; Vij R; Shokeen M
J Nucl Med; 2018 Feb; 59(2):216-222. PubMed ID: 29025987
[TBL] [Abstract][Full Text] [Related]
13. CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET.
Sharma AK; Gupta K; Mishra A; Lofland G; Marsh I; Kumar D; Ghiaur G; Imus P; Rowe SP; Hobbs RF; Gocke CB; Nimmagadda S
Adv Sci (Weinh); 2024 Apr; 11(16):e2308617. PubMed ID: 38421139
[TBL] [Abstract][Full Text] [Related]
14.
Suman SK; Mukherjee A; Pandey U; Chakraborty A; Rakshit S; Tawate M; Sarma HD
Cancer Biother Radiopharm; 2023 Feb; 38(1):38-50. PubMed ID: 36413344
[No Abstract] [Full Text] [Related]
15. Clinical Translation of [
Xavier C; Blykers A; Laoui D; Bolli E; Vaneyken I; Bridoux J; Baudhuin H; Raes G; Everaert H; Movahedi K; Van Ginderachter JA; Devoogdt N; Caveliers V; Lahoutte T; Keyaerts M
Mol Imaging Biol; 2019 Oct; 21(5):898-906. PubMed ID: 30671739
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, preclinical evaluation, and a pilot clinical imaging study of [
Xie Q; Liu T; Ding J; Zhou N; Meng X; Zhu H; Li N; Yu J; Yang Z
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3129-3140. PubMed ID: 33630145
[TBL] [Abstract][Full Text] [Related]
17. CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging.
Ulaner GA; Sobol NB; O'Donoghue JA; Kirov AS; Riedl CC; Min R; Smith E; Carter LM; Lyashchenko SK; Lewis JS; Landgren CO
Radiology; 2020 Jun; 295(3):606-615. PubMed ID: 32255416
[TBL] [Abstract][Full Text] [Related]
18. ImmunoPET Imaging of CD47 with VHH-Derived Tracers in Pancreatic Cancers.
Liang C; Huang W; Zhang Y; Zhang D; An S; Wu Q; Zhao H; Wang C; Huang G; Wei W; Liu J
Mol Pharm; 2023 Aug; 20(8):4184-4195. PubMed ID: 37403817
[TBL] [Abstract][Full Text] [Related]
19. Lyophilization of NOTA-sdAbs: First step towards a cold diagnostic kit for
Baudhuin H; Van Bockstal PJ; De Beer T; Vaneycken I; Bridoux J; Raes G; Caveliers V; Keyaerts M; Devoogdt N; Lahoutte T; Xavier C
Eur J Pharm Biopharm; 2021 Sep; 166():194-204. PubMed ID: 34186190
[TBL] [Abstract][Full Text] [Related]
20. Development of a Ga-68 labeled PET tracer with short linker for prostate-specific membrane antigen (PSMA) targeting.
Moon SH; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK; Jeong JM
Bioorg Med Chem; 2018 May; 26(9):2501-2507. PubMed ID: 29655611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
